On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Apixaban Compares Favorably with Warfarin in Safety, Efficacy
A new analysis of data published in JAMA Cardiology concludes that apixaban (Eliquis) tends to be both safer and more effective than warfarin in patients with atrial fibrillation, regardless of their renal function.
Jerry Bagel: Discussing Treatment Options with Patients
As newer treatment options hit the market for plaque psoriasis patients may have more questions about the best options for them. This is part of the importance of communicating with patients throughout the treatment process.
Jerry Bagel: Approaching Psoriasis Treatment Based on Location
As with many conditions, the kind of care a patient receives can depend on where they live. This can be especially true for dermatology patients needing things like phototherapy. Other factors, like cost and fear, can also impede the treatment process.
Jerry Bagel: Research in Eczema Is Lacking, Despite Progress in Psoriasis
Despite the life of a patient with eczema being in many ways similar to that of a patient with psoriasis, their options for treatment are not nearly as robust as the other dermatologic condition.
Jerry Bagel, MD, Explains How to Measure Success in Psoriasis Treatment
As patients go through the process of treating their plaque psoriasis, there can be different levels of success depending on a number of situations. As a result, measuring success can be a challenge as well.
Jerry Bagel, MD: Evolution of Psoriasis Treatment Means Better Results for Patients
As new treatments for plaque psoriasis are developed the field as a whole is taking a new look at the condition. However, there are still challenges to overcome in diagnosis and treatment.
Migraine Sufferer Speaks for Thousands: “No One Took My Symptoms Seriouslyâ€
September 1st 2016Despite the availability of several treatment options, many people with migraine aren’t satisfied with their outcomes, according to the national Migraine in America 2016 survey created by Health Union.
Studying Faldaprevir and Deleobuvir Use in NS3/4A and NS5B Amino-acid Variants of Hepatitis C
“Although further development of faldaprevir in combination with deleobuvir was terminated due to a strategic decision,†the present study provides valuable information about “antiviral therapies that include a combination of DAAs with a PI and a non-nucleoside thumb-pocket 1 polymerase inhibitor.â€
Biosimilar of Enbrel, a Popular Arthritis and Inflammation Drug, Receives FDA Approval
Erelzi, a biosimilar of Enbrel (etanercept), has received FDA approval. Biosimilars are defined by the organization as being “highly similar to an FDA-approved biological product†while demonstrating “clinically meaningful differences in terms of safety and effectiveness.â€
Major Sebastian Schnellbacher: Applying Lessons from the 4077th to Today's Military
It has been more than 30 years since the popular television show M*A*S*H went off the air but there is still much that can be learned from the show, particularly when it comes to psychiatry in the military.
Major Sebastian Schnellbacher: Making Improvements in Military Psychiatry
As conditions like PTSD have been brought to the forefront work has been done to help not only current service members but also veterans who may be dealing with that and other conditions during and after service.
RNA Assessment Predicts Hepatitis C Relapse Two Weeks into Treatment
August 31st 2016In many cases, the latest treatments for hepatitis C virus (HCV) infection are at least 90% effective at curing the infection; however, there still remains a subset of patients who don’t respond to the new medications.
G. Richard Olds: Working with Foreign Governments to Improve Conditions Locally
As one of the leading educational institutions on the island of Grenada, St. George's University plays a unique role not only in helping the students that come to the school to learn but also those who have already called the island home.